Health Care & Life Sciences » Biotechnology | Tenax Therapeutics Inc.

Tenax Therapeutics Inc.

Tenax Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$8.54
Market Cap
$8.48 M
Shares Outstanding
6.19 M
Public Float
1.16 M

Profile

Address
ONE Copley Parkway
Morrisville North Carolina 27560
United States
Employees -
Website http://www.tenaxthera.com
Updated 07/08/2019
Tenax Therapeutics, Inc. is a pharmaceutical company, which focuses on identifying, developing, and commercializing novel therapeutic products for the critical care market. Its product candidate includes Levosimendan, a calcium sensitizer activator for intravenous use in hospitalized patients with acutely decompensated heart failure. The company was founded on May 26, 1967 and is headquartered in Morrisville, NC.

Financials

View All

Anthony A. DiTonno
Chief Executive Officer & Director
Ronald R. Blanck
Chairman